Psych Observer - Exposing Bad Psychiatrists

By GAYLE WHITE |The Atlanta Journal-Constitution

Thursday, December 18, 2008

In a stern letter to Emory University this week, U.S. Sen. Charles Grassley questions whether renowned psychiatrist Dr. Charles Nemeroff has honestly portrayed some of his activities funded by pharmaceutical companies.

Grassley warns school officials of the potential penalties for making false statements or obstructing a congressional examination.

Nemeroff, an internationally known expert on depression, has become a central figure in an investigation this year by the Senate Finance Committee into whether drug company money paid to physicians compromises medical research and scholarship. Grassley (R-Iowa) is the ranking minority member of the committee.

Grassley’s letter, obtained by The Atlanta Journal-Constitution, questions Emory’s position that some talks by Nemeroff funded by the pharmaceutical company GlaxoSmithKline were educational and did not involve promotion of Glaxo products.
Read the rest…

For almost every behavioural issue, these days there’s a medicine to treat it

Roger Dobson reports
Tuesday, 3 June 2008

Spending too much time on the internet? Worried about a low sex drive, shyness or lack of social skills? Or do you lose your temper too easily, blush too readily or spend too much time and money shopping?

Time was when such behaviours might have been regarded as individual differences, or put down to lack of self control and restraint. But not any more. Increasing numbers of behavioural conditions are being treated with drug therapy. Bereavement issues, blushing, low sex drive, high sex drive, sex addiction, lack of orgasm, gambling, fear of public speaking, stealing, domestic violence and phobias are all being targeted with drugs that are either in clinical trials or already available.

Read the rest…